Christopher Garabedian
Overview
Christopher Garabedian received an average of $5M in total compensation, including $463K in salary, at Sarepta Therapeutics from 2011 to 2015.
2015Sarepta TherapeuticsFormer President and Chief Executive Officer
2014Sarepta TherapeuticsFormer President and Chief Executive Officer
2013Sarepta TherapeuticsFormer President and Chief Executive Officer
2012Sarepta TherapeuticsFormer President and Chief Executive Officer
2011Sarepta TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on May 31, 2016, April 30, 2015, and April 30, 2013.
Related executives
We found 30 more executives who work or worked at Sarepta Therapeutics.
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
Ryan Brown
Sarepta Therapeutics
General Counsel
William Ciambrone
Sarepta Therapeutics
Executive Vice President, Technical Operations
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
David Howton
Sarepta Therapeutics
General Counsel
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
Sandesh Mahatme
Sarepta Therapeutics